The use of cell therapy for the treatment of cerebral palsy has been studied in the Beijing Rehabilitation Center in China, reported in the journal Cell Transplantation. In the study, in which Chinese researchers injected olfactory ensheathing cells (OECs) into the frontal lobes of the brains of 33 children and adolescents with cerebral palsy. The findings, which are at best preliminary, illustrated that the OECs can result in improved neurological function without serious side effects. Prior research, according to the paper, also suggest that OECs may be useful cell transplant options for other neurological diseases including multiple sclerosis, spinal cord injury and amyotrophic lateral sclerosis.
The 2010 report, "Tissue Engineering, Cell Therapy and Transplantation" (Report #S520), details the status of cell therapy (stem cell and other pluripotent) technology and market development in neurology as well as orthopedics, skin/integumentary, cardiology, urology, ob/gyn, gastroenterology, cancer, dental/oral surgery, ophthalmology, organ transplantation and other applications.